<DOC>
	<DOCNO>NCT03005340</DOCNO>
	<brief_summary>Randomized , open-label , single-dose , three-treatment , six-sequence , three-way crossover study evaluate safety pharmacokinetic characteristic coadministration C1-R215 C2-R215 compare administration C1-R215 C2-R215 independently healthy male volunteer</brief_summary>
	<brief_title>A Phase 1 Drug Drug Interaction Clinical Trial C1-R215 C2-R215 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Healthy male 19 45 BW 50kg BMI 18.5 30.0 Subject agree sign informed consent form prior study participation Presence history clinically significant disease Treatment history drug might affect IP within 10days History study drug within 12weeks</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>